<DOC>
	<DOCNO>NCT02677207</DOCNO>
	<brief_summary>To evaluate effect nicotinic allosteric modulator JNJ-39393406 psychometric performance residual depressive symptom patient diagnose unipolar bipolar depression currently DO NOT meet criterion episode Major Depression Manic Episode .</brief_summary>
	<brief_title>The Effects JNJ-39393406 Psychometric Performance Residual Depressive</brief_title>
	<detailed_description>To evaluate effect nicotinic allosteric modulator JNJ-39393406 psychometric performance residual depressive symptom patient diagnose unipolar bipolar depression currently DO NOT meet criterion episode Major Depression Manic Episode . Hypothesis : Allosteric modulation a7nAChR JNJ-39393406 improves psychometric performance residual depressive symptom patient unipolar major depression disorder ( MDD ) bipolar depression ( BPD ) . Outcome measurement : - BACS - MADRS - BNSS - CGI-S- BP , - Questionnaire smoking urge ( QSU ) time first cigarette wake morning , - Readiness discharge scale .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<criteria>1 . Meet DSM V criterion history MDD BPD MINI . 2 . Between 1850 year age , male female subject race , smoker nonsmoker . 3 . Able provide inform consent . All participant patient must sign informed consent document indicate understand purpose study procedure require study willing participate complying study procedure restriction . 4 . Have MADRS ≥ 10 ≤ 34 YMRS &lt; 7 . 5 . In opinion investigator , basic education severity symptom ( psychotic , negative , manic , agitation , depression ) prevent patient attend cognitive task . 6 . In opinion investigator patient safely treat 2 psychotropic medication background therapy ( SOS agitation sleep medication allow addition 2 psychotropics ) . 7 . The background psychotropic ( ) continue throughout 2 week trial must start least 2 week prior baseline day dose allow local regulation change dose make prebaseline 2 week period . 8 . Inpatients outpatient discretion investigator ( If outpatient Readiness Discharge Scale administer baseline visit . ) 1 . Women child bear potential practice contraception . 2 . Psychosis , florid manic major depressive episode 4 week precede baseline day current psychosis . 3 . Patients 2 psychotropic ( hypnotic sleep occasional SOS agitation count ) . 4 . Smokes 40 cigarette per day . 5 . Unstable medical disease ( malignancy , poorly control diabetes , cardiomyopathy , serious pulmonary disease , kidney disease , impair liver function . Particular attention give exclude patient ischemic heart disease ) . 6 . Has clinically significant abnormal 12lead electrocardiogram ( ECG ) Screening Visit 1 determine Investigator . 7 . At significant risk commit suicide , opinion Investigator , currently imminent risk suicide harm others . 8 . Patients current DSMV substance alcohol dependence . 9 . Concurrent delirium , mental retardation , druginduced psychosis , history stroke , brain degenerative disorder brain trauma .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>